abril 16, 2021 Andes Biotechnologies presented in the online version of SLAGO By AndesBio | News | No Comments
mayo 6, 2019 Phase 1b trial of Andes-1537 starts in 6 cancer indications By AndesBio | News | No Comments
marzo 23, 2019 Results from Phase 1a clinical trial for Andes-1537 suggest preliminary signals of efficacy in hard-to-treat cancer By AndesBio | News | No Comments
noviembre 9, 2018 Andes presented on the relevance of curiosity to advances in life sciences at the 350th anniversary of Merck By AndesBio | News | No Comments
agosto 31, 2017 Dr. Luis Burzio was appointed to the Royal Society of Medicine By AndesBio | News | No Comments
julio 26, 2017 Andes Biotechnologies announces a strategic change in its board of directors By AndesBio | News | No Comments
junio 9, 2015 Andes Biotechnologies Announces Manufacturing Agreement with Dalton Pharma Services By AndesBio | News | No Comments
abril 16, 2015 Andes Biotechnologies raises $10 million in a series B financing By AndesBio | News | No Comments
